Compound Detail

CHEMBL5434094

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)OCc3cn(CC4CN(c5cccc(Cl)c5)C(=O)O4)nn3)CCC[C@]21C

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5434094
Phase	Preclinical
Structure Type	MOL
InChI Key	FVGVVBWWBIGFBX-KDHULTEUSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

591.1

MW (Da)

6.83

ALogP

HBA

HBD

86.5

PSA (Å²)

0.28

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 4 meas. best 5.16

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HeLa CHEMBL399	IC50	5.16	5.16	6940.0	1
MGC-803 CHEMBL3706566	IC50	4.75	4.75	17600.0	1
L02 CHEMBL4296457	IC50	4.62	4.62	23890.0	1
HepG2 CHEMBL395	IC50	4.32	4.32	47890.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HeLa	IC50	=	6940.0	nM	5.16	Anticancer activity against human HeLa cells assessed as inhibition of cell grow...	38389893
MGC-803	IC50	=	17600.0	nM	4.75	Anticancer activity against human MGC-803 cells assessed as inhibition of cell g...	38389893
L02	IC50	=	23890.0	nM	4.62	Cytotoxicity against human LO2 cells assessed as reduction in cell viability inc...	38389893
HepG2	IC50	=	47890.0	nM	4.32	Anticancer activity against human HepG2 cells assessed as inhibition of cell gro...	38389893

PubMed	DOI	Target Context	# Activities
38389893	10.1039/d3md00550j	HeLa	1
38389893	10.1039/d3md00550j	HepG2	1
38389893	10.1039/d3md00550j	MGC-803	1
38389893	10.1039/d3md00550j	T-24	1
38389893	10.1039/d3md00550j	L02	1

Data from ChEMBL 36 via Core Engine